253 related articles for article (PubMed ID: 1549625)
1. Suppression of murine hematopoiesis in vivo after chronic administration of zidovudine: evidence that zidovudine-induced anemia is the result of decreased bone marrow-derived, erythropoietin-responsive progenitor cells.
Gallicchio VS; Hughes NK
Proc Soc Exp Biol Med; 1992 Apr; 199(4):459-65. PubMed ID: 1549625
[TBL] [Abstract][Full Text] [Related]
2. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
Gallicchio VS; Hughes NK; Tse KF
Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902
[TBL] [Abstract][Full Text] [Related]
3. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells.
Gallicchio VS; Hughes NK; Hulette BC; Noblitt L
J Leukoc Biol; 1991 Dec; 50(6):580-6. PubMed ID: 1940611
[TBL] [Abstract][Full Text] [Related]
4. Prevention of the hematopoietic toxicity associated with zidovudine in vivo with IL-1 alone or in combination with GM-CSF administered to normal mice.
Gallicchio VS; Hughes NK; Tse KF; Gaines H
Growth Factors; 1993; 9(3):177-83. PubMed ID: 8274295
[TBL] [Abstract][Full Text] [Related]
5. Effect of combination interleukin-3 (IL-3) and granulocyte-macrophage colony stimulating factor (GM-CSF) on hematopoiesis administered to retrovirus-infected immunodeficient mice receiving dose-escalation zidovudine (AZT).
Gallicchio VS; Hughes NK; Tse KF; Ling J; Gaines H; Bowen TE; Uluitu M
Int J Immunopharmacol; 1995 Nov; 17(11):865-78. PubMed ID: 8788116
[TBL] [Abstract][Full Text] [Related]
6. Basic fibroblast growth factor (B-FGF) induces early- (CFU-s) and late-stage hematopoietic progenitor cell colony formation (CFU-gm, CFU-meg, and BFU-e) by synergizing with GM-CSF, Meg-CSF, and erythropoietin, and is a radioprotective agent in vitro.
Gallicchio VS; Hughes NK; Hulette BC; DellaPuca R; Noblitt L
Int J Cell Cloning; 1991 May; 9(3):220-32. PubMed ID: 2061622
[TBL] [Abstract][Full Text] [Related]
7. Comparison of dideoxynucleoside drugs (DDI and zidovudine) and induction of hematopoietic toxicity using normal human bone marrow cells in vitro.
Gallicchio VS; Hughes NK; Tse KF
Int J Immunopharmacol; 1993 Feb; 15(2):263-8. PubMed ID: 8468123
[TBL] [Abstract][Full Text] [Related]
8. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
9. Modulation of murine hematopoiesis in vivo with recombinant murine interleukin-1.
Gallicchio VS; Shedlofsky SI; Swim AT; Robinson JM; Hulette BC; Messino MJ; Doukas MA
J Biol Response Mod; 1989 Aug; 8(4):422-39. PubMed ID: 2666587
[TBL] [Abstract][Full Text] [Related]
10. Additive effect of erythropoietin and heme on murine hematopoietic recovery after azidothymidine treatment.
Harrison J; Kappas A; Levere RD; Lutton JD; Chertkov JL; Jiang S; Abraham NG
Blood; 1993 Dec; 82(12):3574-9. PubMed ID: 8260696
[TBL] [Abstract][Full Text] [Related]
11. In vivo effects of the immunosuppressant 15-deoxyspergualin on hematopoiesis in murine allogeneic bone marrow chimeras. Its thrombopoietic activity and reversal of adverse effects with granulocyte colony-stimulating factor and/or erythropoietin.
Imamura M; Han M; Hashino S; Kobayashi H; Imai K; Kobayashi S; Tanaka J; Zhu X; Kobayashi M; Fujii Y
Transplantation; 1994 Jul; 58(2):214-23. PubMed ID: 7518976
[TBL] [Abstract][Full Text] [Related]
12. In-vivo effect of interleukin 3 and erythropoietin, either alone or in combination, on the hematopoietic toxicity associated with zidovudine.
Gallicchio VS; Hughes NK; Tse KF
Cytokine; 1993 Jan; 5(1):62-71. PubMed ID: 8485306
[TBL] [Abstract][Full Text] [Related]
13. In situ radiation sensitivity of recombinant human granulocyte colony-stimulating factor-recruited murine circulating blood and bone marrow progenitors (colony-forming unit [CFU]-granulocyte-macrophage and CFU-megakaryocyte): evidence for possible biologic differences between mobilized blood and bone marrow.
Scheding S; Media JE; KuKuruga MA; Nakeff A
Blood; 1996 Jul; 88(2):472-8. PubMed ID: 8695794
[TBL] [Abstract][Full Text] [Related]
14. Sustained zidovudine treatment on hematopoiesis in immunodeficient mice.
Gallicchio VS; Hughes NK; Tse KF
Int J Immunopharmacol; 1993 Aug; 15(6):673-81. PubMed ID: 8407052
[TBL] [Abstract][Full Text] [Related]
15. Interaction of stem cell factor and its receptor c-kit mediates lodgment and acute expansion of hematopoietic cells in the murine spleen.
Broudy VC; Lin NL; Priestley GV; Nocka K; Wolf NS
Blood; 1996 Jul; 88(1):75-81. PubMed ID: 8704204
[TBL] [Abstract][Full Text] [Related]
16. Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15.
Pierelli L; Scambia G; Bonanno G; Coscarella A; De Santis R; Mele A; Battaglia A; Fattorossi A; Romeo V; Menichella G; Mancuso S; Leone G
Exp Hematol; 1999 Mar; 27(3):416-24. PubMed ID: 10089903
[TBL] [Abstract][Full Text] [Related]
17. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
18. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
[TBL] [Abstract][Full Text] [Related]
19. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
Scheding S; Media JE; Nakeff A
Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
[TBL] [Abstract][Full Text] [Related]
20. Increased hematopoietic toxicity following administration of interferon-a with combination dideoxynucleoside therapy (zidovudine plus ddI) administered in normal mice.
Gallicchio VS; Scott KW; Hughes NK; Tse KF; Gaines H; Kirk PR; Birch NJ
Life Sci; 1995; 56(3):PL71-81. PubMed ID: 7823768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
